Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +2,990 72,334
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +9,727 82,061
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +26,600 108,661
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +28,690 137,351
2021-02-28 TYLE PRAVEEN EVP, R&D Shares withheld for taxes −16,560 $7.19 $119K 120,791
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −2,990 0
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −9,727 0
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −26,600 26,600
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −28,690 57,380
2021-02-11 TYLE PRAVEEN EVP, R&D Grant or award · Restricted Stock Units +32,100 32,100
2021-02-11 TYLE PRAVEEN EVP, R&D Grant or award · Stock Option (Right to Buy) +96,310 96,310
2020-04-22 TYLE PRAVEEN EVP, R&D Grant or award +19,893 74,188
2020-04-22 TYLE PRAVEEN EVP, R&D Shares withheld for taxes −4,844 $1.96 $9K 69,344
2020-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +2,990 17,969
2020-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +9,726 27,695
2020-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +26,600 54,295
2020-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −2,990 2,990
2020-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −9,726 9,727
2020-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −26,600 53,200
2020-02-06 TYLE PRAVEEN EVP, R&D Grant or award · Restricted Stock Units +86,070 86,070

Page 1 of 2 · 27 trades